Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04188899 · ClinicalTrials.gov registry record
Point-of-care Ultrasound in the Assessment of Snake Bite
A clinical trial of Rattlesnake Bite (Diagnosis), sponsored by University of Arizona.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT04188899: Recruiting study of Rattlesnake Bite (Diagnosis), sponsored by University of Arizona.
NCT04188899 is a study of Rattlesnake Bite (Diagnosis) that is actively recruiting participants, run by University of Arizona. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04188899, a study of Rattlesnake Bite (Diagnosis), is actively recruiting participants, sponsored by University of Arizona.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Early identification of tissue injury from a rattlesnake bite is critical to prevent complications and reduce health care costs. Given the limitations of clinical assessment, there is a need to develop a more objective reproducible, anatomically detailed diagnostic tool for to accurately assess tissue damage and assist with timely administration of antivenom, if needed. Emergency physician performed point-of-care ultrasonography has been shown to be beneficial in the diagnosis and management of skin and soft tissue infections. The innovative use of bedside ultrasound technology can provide new information to individualize antivenom treatment and to improve patient outcomes. The objectives of this study is to compare clinical assessment and bedside ultrasound findings in the detection of tissue injury in emergency department patients with rattle snakebite and determine if bedside ultrasound can alter management (antivenom dosing) in emergency department patients with rattle snakebite.
Primary Outcome
Sonographic skin changes
Conditions Studied
Study Locations (1)
Arizona
- Banner University Medical Center-Tucson - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-11-28 |
| Est. Completion | 2026-12-31 |
What NCT04188899 shows while recruiting
NCT04188899 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Rattlesnake Bite (Diagnosis) appearing as the primary indexed condition, and to 0 interventions.
NCT04188899 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT04188899 about?
NCT04188899 is a clinical study titled "Point-of-care Ultrasound in the Assessment of Snake Bite". Early identification of tissue injury from a rattlesnake bite is critical to prevent complications and reduce health care costs. Given the limitations of clinical assessment, there is a need to develop a more objective reproducible, anatomically detailed diagnostic tool for to accurately assess tiss...
What is the current status of trial NCT04188899?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2019-11-28. Estimated completion is 2026-12-31.
What conditions does trial NCT04188899 study?
This clinical trial studies the following conditions: Rattlesnake Bite (Diagnosis).
Who is sponsoring clinical trial NCT04188899?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04188899 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI